Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease: A randomized, double blind, placebo-controlled study

Journal of Neurology

Volumn 254, Issue 4, 2007, Pages 459-464

  Medeiros, Camila Andrade Mendes ^a   Carvalhedo De Bruin, Pedro Felipe ^a   Lopes, Lívia Ariane ^a   Magalhães, Maria Cecília ^a   De Lourdes Seabra, Maria ^b   Sales De Bruin, Veralice Meireles ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Melatonin; Parkinson's disease; Polysomnography; Sleep; Sleep apnea

Indexed keywords

AMANTADINE; BIPERIDEN; LEVODOPA; MELATONIN; PLACEBO; PRAMIPEXOLE; SELEGILINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MOTOR DYSFUNCTION; MUSCLE ATONIA; OXYGEN SATURATION; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REM SLEEP; SCORING SYSTEM; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIOXIDANTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MELATONIN; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 34249072817     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0390-x     Document Type: Article

References (29)

1. Larsen JP, Tandberg E (2001) Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs 15:267-275
2. Clarenbach P (2000) Parkinson's disease and sleep. J. Neurol 247:20-2
3. Arnulf I (2005) Excessive daytime sleepiness in parkinsonism. Sleep Med 9:185-200
4. Hebert M, Martin SK, Lee C, Eastman CA (2002) The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 33:198-203
5. Dijk DJ, Lockley SW (2002) Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol 92:852-862
6. Cagnacci A (1996) Melatonin in elation to physiology in adult humans. J Pineal Res 21:200-213
7. Arendt J, Skene DJ (2005) Melatonin as a chronobiotic. Sleep Med Rev 9:25-39
8. Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP (2005) Melatonin and sleep in aging population. Exp Gerontol 40:911-925
9. Campos FL, Silva-Júnior FP, De Bruin VMS, De Bruin PFC (2004) Melatonin Improves Sleep in Asthma. Am J Resp Crit Care 170:947-951
10. Dabbeni-Sala F, Di Santo S, Franceschini D, Skaper SD, Giusti P (2001) Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity. FASEB J 15:164-170
11. Absi E, Ayala A, Machado A, Parrado J (2000) Protective effect of melatonin against the 1-methyl-4-phenylpyridinium-induced inhibition of complex I of the mitochondrial respiratory chain. J Pineal Res 29:40-47
12. Willis GL, Armstrong SM (1999) A therapeutic role for melatonin antagonism in experimental models of Parkinson's disease. Physiol Behav 66:785-795
13. Rechtshaffen A, Kales A, editors. A Manual Of Standardized Terminology, Techniques And Scoring System For Sleep Stages Of Human Subjects. Los Angeles CA: BIS/BRI, UCLA; 1968
14. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213
15. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
16. Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41-50
17. Vgontzas AN, Bixler EO, Kales A, Manfredi RL, Tyson K (1994) Validity and clinical utility of sleep laboratory criteria for insomnia. Int J Neurosci 77:11-21
18. Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ (2005) Melatonin for sleep disturbances in Parkinson's Disease. Sleep Med 6:459-466
19. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58:1019-1024
20. Happe S, Anderer P, Pirker W, Klosch G, Gruber G, Saletu B, Zeitlhofer J (2004) Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease. J Neurol 251:1465-1471
21. Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O (2005) Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment. Eur J Neurol 12:199-207
22. Romigi A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P (2005) Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 228:7-10
23. Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M (2005) Sleep apnea syndrome in Parkinson's disease. A casecontrol study in 49 patients. Mov Disord 20:1413-1418
24. Monte FS, da Silva-Junior FP, Braga- Neto P, Nobre e Souza MA, Sales de Bruin VM (2004) Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 217:41-45
25. Seabra ML, Bignotto M, Pinto LR Jr, Tufik S (2000) Randomized, doubleblind clinical trial, controlled with placebo, of the toxicology chronic melatonin treatment. J Pineal Res 29:193-200
26. Dowling GA, Mastick J, Aminoff MJ (2003) Melatonin treatment for insomnia in Parkinson's disease: A pilot Study. Sleep Research Online 5:99-103
27. Bruguerolle B, Simon N (2002) Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol 25:194-201
28. Bordet R, Devos D, Brique S, Touitou Y, Guieu JD, Libersa C, Destee A (2003) Study of circadian melatonin secretion pattern at different stages of Parkinson's disease. Clin Neuropharmacol 26:65-72
29. Camara Magalhaes S, Vitorino Souza C, Rocha Dias T, Felipe Carvalhedo de Bruin P, Meireles Sales de Bruin V (2005) Lifestyle regularity measured by the social rhythm metric in Parkinson's disease. Chronobiol Int 22:917-924